These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15816632)

  • 1. Immunohistochemical staining of cathepsins B, L and stefin A in human hypophysis and pituitary adenomas.
    Strojnik T; Lah TT; Zidanik B
    Anticancer Res; 2005; 25(1B):587-94. PubMed ID: 15816632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsins B and L and their inhibitors stefin B and cystatin C as markers for malignant progression of benign meningiomas.
    Trinkaus M; Vranic A; Dolenc VV; Lah TT
    Int J Biol Markers; 2005; 20(1):50-9. PubMed ID: 15832773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsins B and L are markers for clinically invasive types of meningiomas.
    Strojnik T; Zidanik B; Kos J; Lah TT
    Neurosurgery; 2001 Mar; 48(3):598-605. PubMed ID: 11270551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysosomal cathepsins B and L and Stefin A blood levels in patients with hepatocellular carcinoma and/or liver cirrhosis: potential clinical implications.
    Leto G; Tumminello FM; Pizzolanti G; Montalto G; Soresi M; Gebbia N
    Oncology; 1997; 54(1):79-83. PubMed ID: 8978598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases, but not cathepsins B, H, and L or their inhibitors in peripheral blood of patients with rheumatoid arthritis are potentially useful markers of disease activity.
    Keyszer G; Lambiri I; Keysser M; Keysser C; Nagel R; Burmester GR; Jung K
    Z Rheumatol; 1998 Dec; 57(6):392-8. PubMed ID: 10025098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsins B, H, and L and their inhibitors stefin A and cystatin C in sera of melanoma patients.
    Kos J; Stabuc B; Schweiger A; Krasovec M; Cimerman N; Kopitar-Jerala N; Vrhovec I
    Clin Cancer Res; 1997 Oct; 3(10):1815-22. PubMed ID: 9815568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cathepsin L in glioma progression: comparison with cathepsin B.
    Strojnik T; Kavalar R; Trinkaus M; Lah TT
    Cancer Detect Prev; 2005; 29(5):448-55. PubMed ID: 16183211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells producing cathepsins D, B, and L in human breast carcinoma and their association with prognosis.
    Lah TT; Kalman E; Najjar D; Gorodetsky E; Brennan P; Somers R; Daskal I
    Hum Pathol; 2000 Feb; 31(2):149-60. PubMed ID: 10685628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of cathepsins B, H, L, D and their endogenous inhibitors stefins A and B in head and neck carcinoma.
    Budihna M; Strojan P; Smid L; Skrk J; Vrhovec I; Zupevc A; Rudolf Z; Zargi M; Krasovec M; Svetic B; Kopitar-Jerala N; Kos J
    Biol Chem Hoppe Seyler; 1996 Jun; 377(6):385-90. PubMed ID: 8839984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward understanding recurrent meningioma: the potential role of lysosomal cysteine proteases and their inhibitors.
    Lah TT; Nanni I; Trinkaus M; Metellus P; Dussert C; De Ridder L; Rajcević U; Blejec A; Martin PM
    J Neurosurg; 2010 May; 112(5):940-50. PubMed ID: 19747051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cysteine proteinases and their protein inhibitors stefins, cystatins and kininogens.
    Turk V; Brzin J; Kotnik M; Lenarcic B; Popović T; Ritonja A; Trstenjak M; Begić-Odobasić L; Machleidt W
    Biomed Biochim Acta; 1986; 45(11-12):1375-84. PubMed ID: 3495261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induced expression of cathepsins and cystatin C in a murine model of demyelination.
    Ma J; Tanaka KF; Yamada G; Ikenaka K
    Neurochem Res; 2007 Feb; 32(2):311-20. PubMed ID: 17086443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cysteine proteinases in chondrosarcomas.
    Söderström M; Ekfors T; Böhling T; Aho A; Aro HT; Vuorio E
    Matrix Biol; 2001 Jan; 19(8):717-25. PubMed ID: 11223331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cathepsins B, H, K, L, and S during human fetal lung development.
    Bühling F; Waldburg N; Krüger S; Röcken C; Wiesner O; Weber E; Welte T
    Dev Dyn; 2002 Sep; 225(1):14-21. PubMed ID: 12203716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian characteristics of cathepsins B, H, L, and stefins A and B, potential markers for disease, in normal sera.
    Cimerman N; Brguljan PM; Krasovec M; Suskovic S; Kos J
    Clin Chim Acta; 1999 Apr; 282(1-2):211-8. PubMed ID: 10340450
    [No Abstract]   [Full Text] [Related]  

  • 16. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer.
    Krepela E; Procházka J; Kárová B; Cermák J; Roubková H
    Neoplasma; 1998; 45(5):318-31. PubMed ID: 9921922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of cathepsin B and L expression in vitro in gastric cancer tissues by egg cystatin.
    Saleh Y; Siewiński M; Kielan W; Ziółkowski P; Gryboś M; Rybka J
    J Exp Ther Oncol; 2003; 3(6):319-24. PubMed ID: 14678520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of cathepsins B and L in early gestational decidua and chorionic villi].
    Wang AM; Chen SL; Xing FQ
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1365-8. PubMed ID: 16305957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.
    Parker BS; Ciocca DR; Bidwell BN; Gago FE; Fanelli MA; George J; Slavin JL; Möller A; Steel R; Pouliot N; Eckhardt B; Henderson MA; Anderson RL
    J Pathol; 2008 Feb; 214(3):337-46. PubMed ID: 17985332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of proteolytic cathepsins B, D, and L in periodontal gingival fibroblasts and tissues.
    Trabandt A; Müller-Ladner U; Kriegsmann J; Gay RE; Gay S
    Lab Invest; 1995 Aug; 73(2):205-12. PubMed ID: 7637320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.